2023年12月6日 · Insulin glargine is a long-acting insulin used to treat type 1 and type 2 diabetes in certain patients to improve and maintain blood glucose levels. Insulin glargine is a man-made form of human insulin that is used once daily to provide a base level of insulin that keeps working for 24 hours or longer.

2023年8月11日 · What is Insulin Glargine Solostar Pen? Insulin Glargine Solostar Pen is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. Insulin Glargine Solostar Pen is used to improve blood sugar control in people with diabetes mellitus. Toujeo is for use in adults with type 1 or type 2 diabetes.

2024年7月22日 · Uses for insulin glargine, recombinant. Insulin glargine is a long-acting type of insulin that works slowly, over about 24 hours. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later.

2023年8月21日 · Soliqua is a combination of insulin glargine plus lixisenatide, and Lantus only contains insulin glargine. Both are once-daily injections that are given under the skin (subcutaneously), but Soliqua can only be used in adults with type 2 diabetes whereas Lantus may be used to treat both type 1 and type 2 diabetes in adults and children over the age of six y

2023年8月11日 · During clinical trials, patients receiving insulin glargine U-300 required 17.5% greater dose than patients treated with insulin glargine U-100. Use: To improve glycemic control in patients with type 1 diabetes mellitus. Usual Adult Dose for Diabetes Type 2. Dose should be individualized based on clinical response Insulin-naive:

Observe patients receiving insulin glargine or insulin glargine/lixisenatide and a PPAR-γ agonist for manifestations of heart failure (e.g., excessive/rapid weight gain, shortness of breath, edema); discontinue or reduce dose of PPAR-γ agonist if heart failure develops. Concomitant use of rosiglitazone and insulin therapy not recommended.

Products containing insulin glargine insulin glargine systemic. Brand names: Lantus, Basaglar, Toujeo, Lantus SoloStar, Semglee Drug class: insulin. Insulin glargine systemic is used in the treatment of: Diabetes, Type 1; Type 2 Diabetes; Multi-ingredient medications containing insulin glargine insulin glargine/lixisenatide systemic. Brand name ...

2024年7月22日 · The ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial, an open-labeled, randomized study comparing insulin glargine to standard care in persons 50 years or older with abnormal glucose levels (impaired fasting glucose and/or impaired glucose tolerance) or early type 2 diabetes mellitus and established cardiovascular (CV ...

Insulin glargine Interactions. There are 389 drugs known to interact with insulin glargine, along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 15 are major, 353 are moderate, and 21 are minor.

2024年9月17日 · Insulin glargine differs from human insulin in that the amino acid asparagine at position A21 is replaced by glycine and two arginines remain at the C-terminus of the B-chain. Insulin glargine has a molecular weight of 6063 Da. Insulin Glargine, U-300 injection is a sterile, clear and colorless solution for subcutaneous injection.